103 related articles for article (PubMed ID: 10672060)
1. Lack of cyclin D1 overexpression in gastric carcinogenesis.
Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
[TBL] [Abstract][Full Text] [Related]
2. No evidence for c-erbB-2 overexpression in gastric carcinogenesis.
Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
Histopathology; 1998 Apr; 32(4):335-9. PubMed ID: 9602330
[TBL] [Abstract][Full Text] [Related]
3. Loss of E-cadherin expression in early gastric cancer.
Blok P; Craanen ME; Dekker W; Tytgat GN
Histopathology; 1999 May; 34(5):410-5. PubMed ID: 10231415
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Gao P; Zhou GY; Liu Y; Li JS; Zhen JH; Yuan YP
World J Gastroenterol; 2004 Oct; 10(20):2936-9. PubMed ID: 15378768
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.
Arber N; Gammon MD; Hibshoosh H; Britton JA; Zhang Y; Schonberg JB; Roterdam H; Fabian I; Holt PR; Weinstein IB
Hum Pathol; 1999 Sep; 30(9):1087-92. PubMed ID: 10492044
[TBL] [Abstract][Full Text] [Related]
6. Expression of retinoblastoma and cyclin D1 in gastric carcinoma.
Arici DS; Tuncer E; Ozer H; Simek G; Koyuncu A
Neoplasma; 2009; 56(1):63-7. PubMed ID: 19152247
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
[TBL] [Abstract][Full Text] [Related]
8. Chronology of p53 protein accumulation in gastric carcinogenesis.
Craanen ME; Blok P; Dekker W; Offerhaus GJ; Tytgat GN
Gut; 1995 Jun; 36(6):848-52. PubMed ID: 7615272
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer.
Müller W; Noguchi T; Wirtz HC; Hommel G; Gabbert HE
J Pathol; 1999 Oct; 189(2):186-93. PubMed ID: 10547573
[TBL] [Abstract][Full Text] [Related]
11. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
Feakins RM; Nickols CD; Bidd H; Walton SJ
Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
Ahn MJ; Kim BH; Jang SJ; Hong EK; Lee WM; Baik HK; Park HK; Lee CB; Ki M
J Korean Med Sci; 1998 Oct; 13(5):513-8. PubMed ID: 9811181
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
Kumari S; Puneet ; Prasad SB; Yadav SS; Kumar M; Khanna A; Dixit VK; Nath G; Singh S; Narayan G
Med Oncol; 2016 May; 33(5):40. PubMed ID: 27034264
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer.
Aoyagi K; Koufuji K; Yano S; Murakami N; Terasaki Y; Yamasaki Y; Takeda J; Tanaka M; Shirouzu K
Kurume Med J; 2000; 47(3):199-203. PubMed ID: 11059220
[TBL] [Abstract][Full Text] [Related]
16. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype.
Mylona E; Tzelepis K; Theohari I; Giannopoulou I; Papadimitriou C; Nakopoulou L
Histopathology; 2013 Feb; 62(3):472-80. PubMed ID: 23163571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
